Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer StudyRoisín M. Connolly, Vered Stearns, Michelle A. Rudek et al.|Clinical Cancer Research|2016Cited by 160
ANG1005, a novel brain-penetrant taxane derivative, for the treatment of recurrent brain metastases and leptomeningeal carcinomatosis from breast cancer.Priya Kumthekar, Nuhad K. Ibrahim, Shou‐Ching Tang et al.|Journal of Clinical Oncology|2016Cited by 22